Form 8-K - Current report:
SEC Accession No. 0001437749-25-019574
Filing Date
2025-06-05
Accepted
2025-06-05 17:02:39
Documents
13
Period of Report
2025-05-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20250605_8k.htm   iXBRL 8-K 26063
  Complete submission text file 0001437749-25-019574.txt   160673

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlph-20250530.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20250530_def.xml EX-101.DEF 11806
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20250530_lab.xml EX-101.LAB 15857
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20250530_pre.xml EX-101.PRE 12021
15 EXTRACTED XBRL INSTANCE DOCUMENT acrx20250605_8k_htm.xml XML 2938
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 251027958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)